Bulletin
Investor Alert

New York Markets Open in:

Jasper Therapeutics Inc.

NAS: JSPR

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Aug 15, 2022, 5:15 p.m.

/zigman2/quotes/206872721/composite

$

2.25

Change

+0.15 +7.14%

Volume

Volume 2,531

Quotes are delayed by 20 min

/zigman2/quotes/206872721/composite

Previous close

$ 2.26

$ 2.10

Change

-0.16 -7.08%

Day low

Day high

$2.10

$2.41

Open

52 week low

52 week high

$1.73

$18.88

Open

Annual Financials for Jasper Therapeutics Inc.

Fiscal year is January-December. All values USD millions. 20202021 5-year trend
Sales/Revenue -----
Cost of Goods Sold (COGS) incl. D&A ---21,000566,000
COGS excluding D&A -----
Depreciation & Amortization Expense ---21,000566,000
Depreciation ---21,000566,000
Amortization of Intangibles -----
Gross Income ---(21,000)(566,000)
20202021 5-year trend
SG&A Expense ---20.96M37.36M
Research & Development ---16.18M26.52M
Other SG&A -----
Other Operating Expense -----
Unusual Expense ---10.88M(6.28M)
EBIT after Unusual Expense ---(10.88M)(31.65M)
Non Operating Income/Expense ---(111,000)(80,000)
Non-Operating Interest Income -----
Equity in Affiliates (Pretax) -----
Interest Expense -----
Gross Interest Expense -----
Interest Capitalized -----
Pretax Income ---(31.97M)(31.73M)
Income Tax ---(298,000)(1.1M)
Income Tax - Current Domestic -----
Income Tax - Current Foreign -----
Income Tax - Deferred Domestic -----
Income Tax - Deferred Foreign -----
Income Tax Credits ---298,0001.1M
Equity in Affiliates -----
Other After Tax Income (Expense) -----
Consolidated Net Income ---(31.67M)(30.64M)
Minority Interest Expense -----
Net Income ---(31.67M)(30.64M)
Extraordinaries & Discontinued Operations -----
Extra Items & Gain/Loss Sale Of Assets -----
Cumulative Effect - Accounting Chg -----
Discontinued Operations -----
Net Income After Extraordinaries ---(31.67M)(30.64M)
Preferred Dividends -----
Net Income Available to Common ---(31.67M)(30.64M)
EPS (Basic) ---(11.43)(2.69)
Basic Shares Outstanding ---2.77M11.39M
EPS (Diluted) ---(11.43)(2.69)
Diluted Shares Outstanding ---2.77M11.39M
EBITDA ---(20.96M)(37.36M)
Link to MarketWatch's Slice.